Skip to content
PeptideAgent

Clinics in Massachusetts

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What Massachusetts law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Massachusetts at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving Massachusetts

No verified clinics serving Massachusetts are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Massachusetts

Yes. A Massachusetts resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Massachusetts-licensed prescriber, including through telemedicine, which the Board of Registration in Medicine treats as the practice of medicine held to the in-person standard. Compounded peptides are available only when eligible under federal 503A rules and dispensed under one of the strictest compounding regimes in the country: after the 2012 New England Compounding Center outbreak, Massachusetts created separate sterile compounding licenses, and an out-of-state pharmacy may not ship sterile compounded preparations such as injectable peptides into the state without a Massachusetts nonresident sterile compounding license (M.G.L. chapter 112, section 39J). [1] [2] [3] [4] [5] [6] [7] [8] [10]

Compounded GLP-1 access in Massachusetts

Because compounded GLP-1s are injectable sterile preparations, an out-of-state telehealth program can ship them into Massachusetts only from a pharmacy that holds a Massachusetts nonresident sterile compounding license, which narrows the pool further. [4] [13]

Research use only sellers in Massachusetts

M.G.L. chapter 94 (food and drugs) prohibits selling adulterated or misbranded drugs in Massachusetts, and chapter 112 limits dispensing of prescription drugs to licensed pharmacies and practitioners. [9] [14]

Massachusetts notes on specific peptides

  • Semaglutide: Available branded from any Massachusetts pharmacy by prescription, including by telemedicine from a Massachusetts-licensed physician. Compounded semaglutide injections are limited to the federal patient specific exception since April 22, 2025, and must come from a Massachusetts sterile compounding licensee. [4] [13]
  • BPC-157: Not FDA approved and not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk; a state board cannot authorize what federal law does not. Massachusetts pharmacies apply the federal test, and an injectable BPC-157 preparation would also have to come from a pharmacy holding a Massachusetts sterile compounding license (M.G.L. chapter 112, section 39G) or, if shipped from out of state, a nonresident sterile compounding license (section 39J). [4] [5] [11] [12]

How to check a clinic in Massachusetts

  1. Confirm the prescribing clinician's license with the Massachusetts medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Massachusetts Board of Registration in Pharmacy (Department of Public Health) license lookup. [1] [4] [5] [6] [7] [8] [10]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Massachusetts. [9] [14]

Common questions in Massachusetts

Can I get a GLP-1 prescription in Massachusetts through telemedicine?

Yes, from a Massachusetts-licensed physician. The Board of Registration in Medicine treats telemedicine as the practice of medicine under the same standard of care as an in-person visit, and semaglutide and tirzepatide are not controlled substances. [2] [3]

All peptide legal questions for Massachusetts

Sources

  1. [1]Massachusetts Board of Registration in Pharmacy
  2. [2]Massachusetts Board of Registration in Medicine: physician regulations (243 CMR 2.00), policies, and guidelines
  3. [3]Massachusetts Board of Registration in Medicine Policy 2020-01, Policy on telemedicine (amended)
  4. [4]M.G.L. chapter 112, section 39J, Non-resident pharmacies; licensure; compounded preparations
  5. [5]M.G.L. chapter 112, section 39G, Retail sterile compounding pharmacies; licensure
  6. [6]Chapter 159 of the Acts of 2014, An Act relative to pharmacy practice in the Commonwealth
  7. [7]247 CMR, Board of Registration in Pharmacy regulations (Trial Court Law Libraries compilation)
  8. [8]Board of Registration in Pharmacy: draft regulations, including draft 247 CMR 17.00 (sterile compounding) and 18.00 (non-sterile compounding)
  9. [9]M.G.L. chapter 94, Inspection and sale of food, drugs and various articles
  10. [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA